Paxil Accused Of Causing Birth Defects

Bloomberg News  reported, "GlaxoSmithKline Plc, the world's second-biggest drugmaker,  recently began a trial in Philadelphia in what may be a test case for more than 600 lawsuits over claims its antidepressant drug Paxil causes birth defects. Patients and their parents claim internal company documents produced for trial show Glaxo failed to warn about the risks of Paxil until forced to do so in 2005 by the U.S. Food and Drug Administration." The London-based company "faces two more such trials a month from October through January in state court in Philadelphia."